Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
A prospective study of serum folate levels in patients with solid tumors treated with olaparib.
Journal: The oncologist
Published: May 09, 2025
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment.
Journal: Journal for immunotherapy of cancer
Published: July 23, 2024
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
Journal: Cardio-oncology (London, England)
Published: February 06, 2024
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
Journal: Breast cancer research and treatment
Published: June 05, 2023
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 15, 2023
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2023
Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples.
Journal: Frontiers in microbiology
Published: January 19, 2023
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
Journal: Cardio-oncology (London, England)
Published: December 15, 2022
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.
Journal: Journal of the American College of Radiology : JACR
Published: January 21, 2022
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 21, 2021
Reply to M. R. Van Bockstal et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 02, 2021
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 19, 2021
Last Updated: 09/26/2026